TINA HAMILTON: Open Payments
NPI 1629076054 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 23 payments from 8 companies in 2025. Trend: 2023 $133 · 2024 $447 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $354 |
| AstraZeneca Pharmaceuticals LP | 3 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| Novo Nordisk Inc | 2 | $50 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $33 |
| Lilly USA, LLC | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: JARDIANCE, LOKELMA, Kerendia, Ozempic, TARPEYO, Veltassa, FARXIGA.
Industry payments across MD — which companies pay providers there.
